投稿信息
投稿信息
审稿周期
投稿命中率
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%)
自引率
1.9 %
年文章数
757
NCBI查询
期刊简介
稿件收录要求
稿件收录要求
Chinese Medicine is an open access journal publishing evidence-based, scientifically justified research and review papers in all aspects of Chinese medicine, including - but not limited to - chemistry, biology, pharmacology, pharmaceutics, engineering, clinical applications and socioeconomics that are relevant and significant to Chinese medicine. We particularly welcome studies using interdisciplinary methods and technologies to:
- discover new compounds from Chinese medicinal herbs
- elucidate molecular/cellular targets and mechanisms of action for Chinese medicine
- develop modern drug delivery and molecular pharmaceutic tools for Chinese medicine
- evaluate the outcomes of hypothesis-driven, rationally-designed fundamental, pre-clinical and clinical research We now publish research and review papers, both unsolicited and solicited. We may publish opinion or commentary papers which are by invitation only. Normally, we do not publish such types of papers as case study, technical note or meta-analysis unless the topic is of exceptionally significance and urgency.
- discover new compounds from Chinese medicinal herbs
- elucidate molecular/cellular targets and mechanisms of action for Chinese medicine
- develop modern drug delivery and molecular pharmaceutic tools for Chinese medicine
- evaluate the outcomes of hypothesis-driven, rationally-designed fundamental, pre-clinical and clinical research We now publish research and review papers, both unsolicited and solicited. We may publish opinion or commentary papers which are by invitation only. Normally, we do not publish such types of papers as case study, technical note or meta-analysis unless the topic is of exceptionally significance and urgency.
